Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
58
GRX Quote, Financials, Valuation and Earnings
Last price:
$9.95
Seasonality move
:
2.93%
Day range:
$9.90 - $10.00
52-week range:
$9.21 - $11.24
Dividend yield:
6.02%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
47.4K
Avg. volume:
21.9K
1-year change:
-0.4%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
$9.97 | -- | -- | -- | $0.15 | 6.02% | -- |
|
BME
Blackrock Health Sciences Trust
|
$38.90 | -- | -- | -- | $0.26 | 4.49% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$85.53 | -- | -- | -- | $0.22 | 0.94% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.85 | -- | -- | -- | $0.06 | 0.7% | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
$20.75 | -- | -- | -- | $0.18 | 5.21% | -- |
|
THW
Tekla World Healthcare Fund
|
$11.89 | -- | -- | -- | $0.12 | 6.87% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | 1.697 | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | 1.043 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.875 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 1.383 | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | 1.254 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 1.251 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
Gabelli Healthcare & WellnessRx Trust vs. Competitors
-
Which has Higher Returns GRX or BME?
Blackrock Health Sciences Trust has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Blackrock Health Sciences Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- BMEBlackrock Health Sciences Trust-- -- -- -
What do Analysts Say About GRX or BME?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Blackrock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Blackrock Health Sciences Trust, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Blackrock Health Sciences Trust.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 BMEBlackrock Health Sciences Trust0 0 0 -
Is GRX or BME More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 1.084, which suggesting that the stock is 8.401% more volatile than S&P 500. In comparison Blackrock Health Sciences Trust has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.42%.
-
Which is a Better Dividend Stock GRX or BME?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.15 per share corresponding to a yield of 6.02%. Blackrock Health Sciences Trust offers a yield of 4.49% to investors and pays a quarterly dividend of $0.26 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Blackrock Health Sciences Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or BME?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Blackrock Health Sciences Trust quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Blackrock Health Sciences Trust's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Blackrock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Blackrock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- BMEBlackrock Health Sciences Trust-- -- -- --
-
Which has Higher Returns GRX or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About GRX or PJP?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is GRX or PJP More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 1.084, which suggesting that the stock is 8.401% more volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.638%.
-
Which is a Better Dividend Stock GRX or PJP?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.15 per share corresponding to a yield of 6.02%. Invesco Pharmaceuticals ETF offers a yield of 0.94% to investors and pays a quarterly dividend of $0.22 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or PJP?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns GRX or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About GRX or RSPH?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is GRX or RSPH More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 1.084, which suggesting that the stock is 8.401% more volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.889, suggesting its less volatile than the S&P 500 by 11.125%.
-
Which is a Better Dividend Stock GRX or RSPH?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.15 per share corresponding to a yield of 6.02%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.7% to investors and pays a quarterly dividend of $0.06 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or RSPH?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
-
Which has Higher Returns GRX or THQ?
abrdn Healthcare Opportunities Fund has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat abrdn Healthcare Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- -
What do Analysts Say About GRX or THQ?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than abrdn Healthcare Opportunities Fund, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than abrdn Healthcare Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 THQabrdn Healthcare Opportunities Fund0 0 0 -
Is GRX or THQ More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 1.084, which suggesting that the stock is 8.401% more volatile than S&P 500. In comparison abrdn Healthcare Opportunities Fund has a beta of 0.953, suggesting its less volatile than the S&P 500 by 4.653%.
-
Which is a Better Dividend Stock GRX or THQ?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.15 per share corresponding to a yield of 6.02%. abrdn Healthcare Opportunities Fund offers a yield of 5.21% to investors and pays a quarterly dividend of $0.18 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. abrdn Healthcare Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or THQ?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than abrdn Healthcare Opportunities Fund quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than abrdn Healthcare Opportunities Fund's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while abrdn Healthcare Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for abrdn Healthcare Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- --
-
Which has Higher Returns GRX or THW?
Tekla World Healthcare Fund has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About GRX or THW?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Tekla World Healthcare Fund, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is GRX or THW More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 1.084, which suggesting that the stock is 8.401% more volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.947, suggesting its less volatile than the S&P 500 by 5.261%.
-
Which is a Better Dividend Stock GRX or THW?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.15 per share corresponding to a yield of 6.02%. Tekla World Healthcare Fund offers a yield of 6.87% to investors and pays a quarterly dividend of $0.12 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or THW?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
